FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:65-67 January 3, 2002 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Uemura et al. (Sept. 13 issue)¹ make an important contribution to our understanding of the complications of Helicobacter pylori infection, but I have a question regarding the ethics of their study. The authors enrolled 1526 patients, of whom 1246 had H. pylori infection. Of the H. pylori–positive patients, 297 had gastric ulcers and 275 had duodenal ulcers. Hence, 572 patients had a condition for which treatment to eradicate the H. pylori infection is indicated. The remaining H. pylori–positive patients had gastric polyps and nonulcer dyspepsia, conditions for which eradication treatment is not currently indicated.

Eradication . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Stoicov, C., Cai, X., Li, H., Klucevsek, K., Carlson, J., Saffari, R., Houghton, J. (2005). Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation. Infect. Immun. 73: 6311-6321 [Abstract] [Full Text]  
• MacLennan, A. H, Lawton, B., Baber, R. J, Baum, M., Dixon, J M (2002). Hormone replacement therapy and the breast. BMJ 324: 915-915 [Full Text]